A detailed history of M3 Advisory Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, M3 Advisory Group, LLC holds 2,984 shares of NVO stock, worth $306,247. This represents 0.26% of its overall portfolio holdings.

Number of Shares
2,984
Previous 2,844 4.92%
Holding current value
$306,247
Previous $406 Million 12.47%
% of portfolio
0.26%
Previous 0.33%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$119.07 - $145.42 $16,669 - $20,358
140 Added 4.92%
2,984 $355 Million
Q2 2024

Jul 19, 2024

BUY
$122.71 - $146.91 $62,213 - $74,483
507 Added 21.69%
2,844 $406 Million
Q1 2024

Apr 29, 2024

BUY
$102.11 - $135.92 $31,756 - $42,271
311 Added 15.35%
2,337 $300 Million
Q4 2023

Mar 19, 2024

BUY
$87.78 - $105.45 $177,842 - $213,641
2,026 New
2,026 $210 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track M3 Advisory Group, LLC Portfolio

Follow M3 Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M3 Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on M3 Advisory Group, LLC with notifications on news.